Drug profile · INN
calcium chloride
DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER
calcium chloride (DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER) is a dihydrofolate reductase inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: irrigation. Current US regulatory status: approved.
Drug details — calcium chloride
- US status
- approved
- Class
- —
- Route
- IRRIGATION
- Patents
- 20
- Programs
- 91
- Data quality
- 0.89
Quick answer
calcium chloride (DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER) is a dihydrofolate reductase inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: irrigation. Current US regulatory status: approved.
Key facts
Mechanism of action
Dihydrofolate reductase inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
-
US 12077549
Pentaaza macrocyclic ring complexes possessing oral bioavailability
granted -
US 11885817
Biomarkers and methods for detection of seizures and epilepsy
granted -
CA 3244873
TRAITEMENT PRÉVENTIF DE LA MIGRAINE
granted -
US 11692030
Biomarkers and methods for detection of seizures and epilepsy
granted -
WO 2023077094
TRAITEMENT D'UN TROUBLE DÉPRESSIF MAJEUR
granted -
US 2023130736
METHODS OF TREATING MIGRAINE
granted -
US 11622968
Heterocyclic modulators of lipid synthesis
granted -
US 11612608
Methods of treating oral mucositis
granted -
US 11598782
Biomarkers and methods for detection of seizures and epilepsy
granted -
US 2022380379
PHARMACEUTICAL COMPOUNDS
granted -
US 2021387969
BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 AND/OR M4 RECEPTOR AGONISTS
granted -
CA 3177686
COMPOSITIONS COMPRENANT DE LA TROPOELASTINE RETICULEE A DE L'ACIDE HYALURONIQUE ET LEURS PROCEDES D'UTILISATION
granted -
US 11066433
Pentaaza macrocyclic ring complexes possessing oral bioavailability
granted -
US 11008622
Biomarker for predicting sensitivity to EGFR-targeting agent, and use thereof
granted -
CA 3152006
TROPOELASTINE DESTINEE A ETRE UTILISEE DANS LE TRAITEMENT DE LA CICATRISATION DE L'ACNE
granted -
US 10610533
Methods of treating oral mucositis
granted -
US 10597415
Pentaaza macrocyclic ring complexes possessing oral bioavailability
granted -
WO 2020012244
TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AU MOYEN DE BRAZIKUMAB
granted -
US 10350193
Super-oxide dismutase mimetics
granted -
WO 2019016609
TRAITEMENT DE LÉSIONS NON INFLAMMATOIRES
granted
Frequently asked questions
What is calcium chloride?
calcium chloride (DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER) is a dihydrofolate reductase inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: irrigation. Current US regulatory status: approved.
What is the brand name for calcium chloride?
DIALYTE LM/ DEXTROSE 4.25% IN PLASTIC CONTAINER is a marketed brand name for calcium chloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of calcium chloride?
calcium chloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.